GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

Double Medical Technology 002901.SZ · CNY

Health Care · Shenzhen · 🇨🇳 China

Compare

41.30

-2.36%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Double Medical Technology

Its shares trade on Shenzhen under the ticker 002901.SZ. It has been listed since 22 September 2017. In the fiscal year to 31 December 2025, it reported revenue of CN¥2.60bn and net income of CN¥599.6m. At that date it held total assets of CN¥4.92bn and shareholders' equity of CN¥3.57bn.

Double Medical Technology, Inc. engages in production, research and development and sale of medical consumables. The company is headquartered in Xiamen, Fujian. The company went IPO on 2017-09-22. The main products of the Company include orthopedic trauma implant materials, spinal implant materials and nerve surgical implant materials. Also, the Company manufactures surgical instruments. The firm distributes its products in domestic and overseas markets.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
22 Sept 2017
Employees
3,793

Leadership

Pay as last reported

  • Mr. Zhixiong LinChairman of the Board, since 2004CN¥598,800
  • Mr. Zhijun LinVice Chairman of the Board, since 2008CN¥551,800
  • Ms. Danhe ChenChief Financial OfficerCN¥525,900
  • Mr. Dongyang RuanChief Administrative OfficerCN¥541,000
  • Mr. Jiong LuoGeneral Manager, Director, since 2011CN¥1.3m
  • Mr. Xiannan HuaSecretary of the Board
  • Ms. Xiaoping LinDirector
  • Ms. Hongzhen LinIndependent Director
  • Mr. Zhihua WeiIndependent Director
  • Mr. Wei XiaoIndependent DirectorCN¥100,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
30
Environment
2
Social
20
Governance
68
Carbon reduction policy
No
Human rights policy
No

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Produces orthopedic trauma implant materials
  • Manufactures spinal implant materials
  • Distributes products in domestic and overseas markets

Weaknesses

  • No specific weaknesses mentioned in the provided information
  • No details on financial performance provided
  • No information on market share or competitive position

Opportunities

  • Expansion into international markets for medical consumables
  • Growth potential in health care sector
  • Research and development focus on medical products

Threats

  • No specific threats mentioned in the provided information
  • No details on regulatory challenges
  • No information on competition in the health care industry

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.